Results published in The Lancet show that GlaxoSmithKlines Synflorix is very effective in preventing invasive pneumococcal disease.
Results published in The Lancet show that GlaxoSmithKlines Synflorix is very effective in preventing invasive pneumococcal disease.
Read More